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Abstract
Background: Obesity rates are higher among females than males potentially due to changing
food intake across the menstrual cycle. Food intake is partially regulated by circulating appetiteregulating hormones that can be influenced by the menstrual hormones estradiol and
progesterone. Purpose: Examine whether changes in female sex hormones across the menstrual
cycle are related to appetite-regulating hormones. Methods: 8 healthy young females were
tested during the follicular, ovulatory, and luteal phases; phases were confirmed by fasting
plasma hormone concentrations. Blood samples were taken after an overnight fast, as well as
30, 60, and 90 min post-prandially to test the concentrations of acylated ghrelin and active GLP1. Perceived hunger, fullness, satisfaction, and prospective food intake were collected
immediately prior to blood samples. Resting metabolic rate and substrate oxidation were tested
through indirect calorimetry. Results: Menstrual cycle phase had no effect on acylated ghrelin
(P=0.959) or active GLP-1 (P=0.650). Post-prandial fullness was greater during the OP
compared to FP (P=0.02) and approached significance with the LP (P=0.06) but there was no
difference in other perceptions of appetite. There was no effect of menstrual cycle phase on
resting metabolic rate (P=0.961), carbohydrate oxidation (P=0.603), or fat oxidation rate
(P=0.485). Conclusion: Acylated ghrelin and active GLP-1 are unlikely to explain the
previously documented changes in energy intake across the menstrual cycle though perceived
fullness can be elevated during the luteal phase. Taken together, this suggests that sensitivity to
appetite-regulating hormones might fluctuate across the menstrual cycle.
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Chapter 1 - Literature Review
Background:
Obesity has become a worldwide epidemic afflicting ~1.6 billion people worldwide (1).
A majority of Canadians are currently overweight or obese (2) with an economic burden of $4.3
billion in 2004, ~2.5% of total health care costs (3). Obesity is generally caused by a sustained
increase in energy intake (i.e. over eating) and decreased energy expenditure (i.e. increasingly
sedentary behaviour). Together these produce a chronic positive energy balance that inevitably
leads to increased storage of energy, primarily as fat. At the same time, rates of obesity (body
mass index >30) and morbid obesity (body mass index >40) are higher among females than
males (4,5) and overweight females are more likely to become obese compared to overweight
males (6). Unfortunately, despite ~52% of Canadian females currently trying to lose weight (7),
exercise interventions are often far less effective at improving body composition in females than
males (8-11). The difficulty females experience with weight management might be partly
explained by fluctuations in female sex hormones, namely estradiol and progesterone, associated
with the menstrual cycle as these hormones are known to influence energy intake and energy
expenditure (12-16). Unfortunately, females remain largely under-researched in physiology (17)
making it imperative to conduct studies on female-specific physiology to understand the
aforementioned problems that females experience with weight management.
Appetite Regulation:
Overview. The control of energy intake is a complex system incorporating psychological, social,
environmental, behavioural, and physiological components (18). The complexity of appetite
regulation makes it exceedingly difficult to determine how any single factor will contribute to
actual energy intake. Moreover, the difficulty controlling for environmental and social factors
9

makes understanding the more readily modifiable factors that influence eating behaviour, such
as appetite-regulating hormones, important for developing our understanding of appetite
regulation. Physiologically, circulating gut-derived endocrine signals acutely respond to feeding
and also reflect total adiposity and energy balance to regulate energy intake (19).

These

circulating hormones are integrated in the arcuate nucleus (ARC) of the hypothalamus to
mediate hunger, satiety, and energy intake (20,21).

Currently the only known orexigenic

(appetite-stimulating) gut-derived hormone is ghrelin, secreted from the stomach, that induces
hunger by stimulating the NPY and AgRP neurons in the ARC (22). Whereas, there are
numerous anorexigenic (satiety-inducing) hormones, including glucagon-like peptide-1 (GLP-1)
that creates satiating effects through delaying gastric emptying and incretin effects (20) (Figure
1).

Ghrelin. Ghrelin is a 28-amino acid peptide hormone synthesized predominantly by specialized
cells in the stomach (22). Recently it has become possible to accurately measure acylated
ghrelin (AG), the active form of ghrelin. Acylation of ghrelin involves the addition of an
octanoyl group by the enzyme ghrelin O-acyl transferase (23) and is rapidly degraded if not
inhibited (22,24). Although AG represents only 10-20% of total circulating ghrelin it is believed
to be more important in regards to appetite stimulation (25).
In animal models, exogenously administered ghrelin increases energy intake (26).
Similarly, elevated concentrations of ghrelin stimulates energy intake in humans (26).
Moreover, circulating ghrelin concentrations increase while fasting and rapidly decrease after
eating (26-28), peaks in ghrelin precede increased perceptions of hunger by only a short time
(29), are strongly associated with perceptions of hunger (30).

Taken together, these data
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Figure 1: Schematic of gut-derived appetite-regulating hormones and the mechanisms through which
they control energy intake. Ghrelin stimulates hunger by interacting with NPY/AgRP neurons in the
arcuate nucleus. GLP-1 functions through non-hypothalamic mechanisms, including incretin effects and
delaying gastric emptying. Continuous lines represent stimulatory effects while dashed lines represent
inhibitory effects.

implicate ghrelin in the stimulation of hunger and energy intake. Concentrations of AG are
suppressed within min of food consumption and begin to rise around 1.5-2 h post-prandially
(30), although this can be modulated by various factors, including macronutrient composition
(31) or an individual’s body composition (32).

Glucagon-like peptide (GLP-1).

GLP-1 is an anorexigenic gut-derived peptide secreted

primarily from the small intestine (33). Bioactive GLP-1 is generated from two circulating
forms, GLP-17-37 and GLP-17-36 (34). Both forms of GLP-1 are equally potent (34) but in human
plasma GLP-17-36 represents the majority of active circulating active GLP-1 (35). Following
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release, GLP-1 is rapidly degraded by dipeptidyl peptidase-4 (DPP-IV) to its inactive form GLP19-36 (34).
In animals, the absence of GLP-1 produces bodyweight gain due to increased energy
intake compared to GLP-1 replete animals (36). In humans, increased concentrations of GLP-1
decrease hunger (37) and reduce energy intake (38). These data reflect GLP-1’s anorexigenic
effects. GLP-1 concentrations begin to increase within min of food ingestion and remain
elevated for ~1 h (33).

Similarly to ghrelin, secretion of GLP-1 can be influenced by

macronutrient composition (39) or an individual’s body composition (40). The mechanisms by
which GLP-1 induces satiety likely include stimulating insulin secretion, inhibiting the release of
glucagon, and delaying gastric emptying (41).

The Menstrual Cycle:
Basic Physiology. The menstrual cycle is regulated by the interaction of pituitary hormones,
including gonadotropin-releasing hormone, luteinizing hormone (LH), follicle-stimulating
hormone (FSH), and the ovarian hormones progesterone and estrogen (Figure 2) (42). There are
various forms of estrogen but estradiol is the most biologically active form in young healthy
women (16,17). The female menstrual cycle can be divided into discrete phases based on its
hormonal profile. For instance, the follicular phase (FP) beings with menses, ends at ovulation,
and is characterized by relatively low concentrations of estradiol and progesterone (43). Near
the end of the FP there is a surge of estradiol that triggers the secretion of LH and FSH to induce
ovulation. Once ovulation (i.e. release of the oocyte/egg) has occurred, the resulting corpus
luteum within the ovary begins to secrete large amounts of progesterone. Consequently, the
luteal phase (LP) is characterized by a progesterone-dominated state, although estradiol is also
12

elevated relative to the FP (44). The LP lasts from ovulation until menses of the next menstrual
cycle (45). While previous research has demonstrated that gonadotropin-releasing hormone, LH,
and FSH do not correlate with eating in female rats (46), estradiol and progesterone play an
important role in energy intake.

Menstrual Cycle and Energy Intake.

It is well documented that energy intake fluctuates

throughout the menstrual cycle and that changes coincide with fluctuations in ovarian hormones
(15,47-49) (Figure 3). Daily energy intake is lowest during ovulation (13,14,46) which is
attributed to the anorexigenic effects of estradiol. Following ovulation, energy intake increases
by up to 90-500 kcal/day, or an increment of 3.9-34.7%, during the LP compared to the FP
(15,50-53). The increased energy intake potentially reflects the anti-estrogenic and orexigenic
properties of progesterone (45,54). Indeed, females may consume ~10% more during one-half
of their menstrual cycle which is certainly capable of influencing energy balance (46) and
eventually body weight. Importantly, these changes in energy intake are explained entirely by
differences in the caloric intake at each meal, as opposed to changes in the frequency of energy
intake (46,55). Therefore, it seems reasonable to speculate that distinct hormonal responses
occur post-prandially during each menstrual phase. For example, AG might decrease more
rapidly or profoundly post-prandially during the OP, thereby reducing perceptions of hunger and
energy intake in this phase. In this light, it is particularly important for research to investigate
how appetite-regulating hormones respond to feeding throughout the menstrual cycle.

Menstrual Cycle and Appetite-Regulating Hormones. In light of the aforementioned changes in
energy intake across the female menstrual cycle, it is conceivable that female sex hormones are
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altering hormones that regulate energy intake. Estradiol is a potent anorexigenic agent that is at
least partly responsible for the decreased energy intake during ovulation (48,49). Estradiol is an
inhibitory signal that links the hypothalamic–pituitary–gonadal axis to the neural control of
feeding and decreases energy intake by reducing the quantity of food consumed at each meal
(43). Estradiol’s anorexigenic effect can be observed in ovariectomized rats who consequently
express very low concentrations of estradiol, hyperphagia, and a 10-30% increase in body fat
(56) and the reversal of these effects by estradiol treatment alone (57).
Estradiol may produce its anorexigenic effect through interactions with appetiteregulating gut hormones.

Indeed, diminished numbers of ghrelin-producing cells, ghrelin

mRNA concentrations in the stomach, and plasma ghrelin concentrations were all observed
when estradiol was exogenously administered to ovariectomized rats (58). Furthermore, total
ghrelin no longer stimulated energy intake in ovariectomized rats who received estradiol
Figure 2: Fluctuations in female sex hormones
and energy intake across the menstrual cycle.
Adapted from (Hirschberg et al. 2012)1

infusions, implying that the orexigenic
potency of ghrelin is diminished by
estradiol (16). Finally, human females with
hypothalamic

amenorrhea

who

consequently exhibit lower than average
estradiol

concentrations

also

express

concomitantly greater (44%) total ghrelin
concentrations compared to their estradiolreplete counterparts (59).
As ghrelin producing cells possess estradiol receptors (58), this suggests a direct
mechanism for how AG production could be influenced by estradiol, it is less clear how GLP-1
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could be effected.

One potential mechanism is altered gastric emptying throughout the

menstrual cycle. Gastric emptying is an important regulator of GLP-1 secretion (60), but
currently there are conflicting reports on whether gastric emptying is altered by female sex
hormones (61-63). At the same time, there is evidence that estradiol can increase the satiating
potency of GLP-1, although it is unclear how this occurs given that central GLP-1 receptors do
not possess estrogen receptors (46).
Estradiol can also influence appetite and energy intake through the stimulation of
estradiol receptors located in various regions of the brain, especially the hypothalamus. This is
supported by an observable decrease in eating when dilute estradiol is implanted directly into the
hypothalamus in ovariectomized rats (64). Furthermore, the NPY/AgRP and POMC/CART
neurons within the hypothalamus possess abundant estradiol receptors so it is possible that
estradiol exerts its satiety effect directly through these neurons which play important roles in the
regulation of energy intake (65-67).
An important limitation of utilizing the menstrual cycle to test the effects of sex
hormones is that progesterone cannot be isolated since there is no time when progesterone alone
is elevated (17). For this reason, the effects of progesterone are less understood than estradiol.
However, while progesterone alone does not seem to significantly alter energy intake in
ovariectomized rats unless it is administered in supraphysiological doses (68) there is support for
an orexigenic effect of progesterone in human females (69). In particular, the increased hunger
accompanying pregnancy has been partially attributed to the effects of progesterone on specific
neurons in the ARC (70). Also, food cravings are more frequent and intense during the LP
which has been attributed to progesterone (15,69). It is possible that the orexigenic effect of
progesterone is actually due to its antagonizing and suppressing estradiol’s effects. Many of
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estradiol’s metabolic actions are antagonized by progesterone (45) so it may be that progesterone
can inhibit the anorexigenic effect of estradiol. Although it is not exactly clear how this
happens, when progesterone levels were artificially elevated in rhesus monkeys, estradiol levels
were diminished and the estradiol surge that precedes ovulation did not occur (71). Regardless
of the specific mechanism, progesterone seems able to stimulate energy intake and weight gain
suggesting that it could contribute to the greater energy intake in the progesterone-dominated
LP.

Menstrual Cycle and Energy Expenditure. To fully understand how the menstrual cycle could
influence weight maintenance it is important to examine both components of energy balance,
namely energy intake and energy expenditure. The greatest component of daily energy turnover
is generally resting metabolic rate (72).

Studies consistently indicate that daily energy

expenditure fluctuates throughout the menstrual cycle (73-77).

During the LP, energy

expenditure can increase up to 279 kcal/day, or 2.5-11.5%, compared to the FP (43). Elevated
energy expenditure during the LP may result, at least in part, from the hyperthermic effects of
progesterone (45).

Moreover, many of the changes that occur during pregnancy, a very

energetically costly and progesterone-dominated state, are also observed during the LP,
including a 0.3-0.5 °C increase in body temperature (45).

Taken together, these data

demonstrate the importance of considering both energy expenditure and energy intake when
exploring how the female menstrual cycle affects weight management.

Teleological Explanation.

Compared to males, females consistently demonstrate greater

maintenance of energy balance (>99.5% accuracy over a year) in response to acute energy
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deficits (72,78-80). This precise maintenance is probably driven by the relationship between
energy balance and reproductive success in females (81). In females, even a modest energy
deficit can suppress ovulatory cycles and inhibit the hypothalamic–pituitary–gonadal axis (82)
while there appears to be no major disturbances in reproductive function when large energy
deficits exist in males (81). Because lactation and parental thermoregulatory behaviours are
extremely energetically costly in mammals (83) it seems intuitive that a hormonal milieu able to
drive energy intake would exist during pregnancy. Indeed, the increased progesterone and
estradiol during pregnancy are similar to that during the LP. Therefore, the LP may represent a
“gestational-preparation stage” whereby females are preparing for pregnancy to occur, as it
would around ovulation, the stage immediately before the LP. This would be an evolutionarily
pertinent function as even a small energy deficit at the early stages of pregnancy could have
detrimental effects on fetal development.
Summary:
Females experience predictable fluctuations in ovarian hormones across the menstrual
cycle and these hormones can influence energy intake and energy expenditure. Past research on
appetite-regulating hormones has focused on males, with the only studies on females occurring
during the early FP (84-86) when hormone concentrations are lowest. Although informative,
studying one phase that represents only ~50% of adult female life provides an incomplete
understanding and can lead to inappropriate conclusions. Considering the interactions between
sex and appetite-regulating hormones it seems reasonable that these could be at least partially
responsible for the changes in energy intake across the menstrual cycle.
Therefore, the purpose of the current project was to investigate the effect of menstrual
phase on appetite-regulating hormones and perceptions of appetite.

We hypothesize that
17

compared to the OP and FP, there will be elevated concentrations of AG, perceived hunger, and
low active GLP-1 during the LP, while progesterone is increased. Conversely, during OP, with
its elevated estradiol concentrations, there will be lower AG but greater concentrations of active
GLP-1 and a concomitantly reduced hunger compared to both the FP and LP. These results will
provide important information on the mechanisms of weight management in females.
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Chapter 2

Menstrual cycle phase has no effect on acylated ghrelin and GLP-1
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Abstract
Background: Obesity rates are higher among females than males potentially due to changing
food intake across the menstrual cycle. Food intake is partially regulated by circulating appetiteregulating hormones that can be influenced by the menstrual hormones estradiol and
progesterone. Purpose: Examine whether changes in female sex hormones across the menstrual
cycle are related to appetite-regulating hormones. Methods: 8 healthy young females were tested
during the follicular, ovulatory, and luteal phases; phases were confirmed by fasting plasma
hormone concentrations. Blood samples were taken after an overnight fast, as well as 30, 60,
and 90 min post-prandially to test the concentrations of acylated ghrelin and active GLP-1.
Perceived hunger, fullness, satisfaction, and prospective food intake were collected immediately
prior to blood samples. Resting metabolic rate and substrate oxidation were tested through
indirect calorimetry. Results: Menstrual cycle phase had no effect on acylated ghrelin (P=0.959)
or active GLP-1 (P=0.650). Post-prandial fullness was greater during the OP compared to FP
(P=0.02) and approached significance with the LP (P=0.06) but there was no difference in other
perceptions of appetite. There was no effect of menstrual cycle phase on resting metabolic rate
(P=0.961), carbohydrate oxidation rate (P=0.603), or fat oxidation rate (P=0.485). Conclusion:
Acylated ghrelin and active GLP-1 are unlikely to explain the previously documented changes in
energy intake across the menstrual cycle though perceived fullness can be elevated during the
luteal phase. Taken together, this suggests that sensitivity to appetite-regulating hormones might
fluctuate across the menstrual cycle.
KEYWORDS: GHRELIN, GLP-1, APPETITE, MENSTRUAL CYCLE, FEMALE, RESTING
METABOLIC RATE
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Introduction
Despite ~50% of North American females currently trying to lose weight (1,2),
overweight females are more likely to become obese compared to overweight males (3) partly
explaining the greater rates of obesity (body mass index >30) and morbid obesity (body mass
index >40) among females (4,5). Moreover, university is an important time as 60% of first year
students gain 3.5 kg (6). In light of this, it is important we explore the regulation of energy
intake by healthy young females to possibly prevent the progression towards unhealthy body
weight gain. The difficulty females experience with weight management might be explained by
female sex hormones, namely progesterone (P4) and estradiol (E2), the most biologically potent
form of estrogen (7,8). These hormones fluctuate across the menstrual cycle and are known to
influence energy intake and energy expenditure (7,9-12).
The female menstrual cycle can be divided into three phases based on their associated
hormonal milieu. The first phase is the follicular phase (FP) that is characterized by relatively
low concentrations of both E2 and P4 and begins with menses (day 1) and continues until
ovulation (approximately day 12) (13). Immediately prior to ovulation (OP), between days 7-10,
there is a surge in E2 but no change in P4 (13). The third phase is the luteal phase (LP) during
which time both E2 and P4 concentrations are elevated compared to the FP but is dominated by
P4 and lasts from ovulation until the next menses. Interestingly, relative to the FP, energy intake
consistently decreases around OP and increases during the LP (11,12,14,15).
Estradiol has potent anorexigenic (satiety-inducing) effects reflected by the reduced
energy intake around ovulation (11,16). Moreover, there is evidence that E2 can influence the
production of ghrelin (17) as well as the potency of ghrelin (7), leptin (18), and cholecystokinin
(19). Conversely, the orexigenic (appetite-inducing) effect of P4 can be seen by the increased
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energy intake during the LP when P4 concentrations spike (12,20-22). It is not exactly clear how
P4 affects energy intake, although it does have anti-estrogenic qualities (23) and thus might
suppress E2’s anorexigenic effects thereby producing an orexigenic drive. There is also evidence
that menstrual cycle phase can alter the production of GLP-1 (24).

Importantly, during

anovulatory cycles, where P4 does not increase in the LP, energy intake no longer increases (12)
supporting that the fluctuating sex hormones are responsible for changing energy intake
(21,25,26).
The physiological control of energy intake is partly mediated by circulating gut-derived
hormones that either stimulate appetite (i.e. orexigenic) or induce satiety (i.e. anorexigenic) (27).
Currently the only known orexigenic gut hormone is ghrelin, synthesized predominately by
specialized endocrine cells in the stomach, and then activated by the addition of an octanoyl
group to acylated ghrelin (AG) (28,29).

Importantly, peaks in ghrelin precede increased

perceptions of hunger by only a short time (30) and are strongly associated with hunger and
energy intake (31). Although AG represents only 10-20% of total circulating ghrelin, it is
thought to be more important in terms of appetite regulation (32,33). In opposition, various
hormones such as glucagon-like peptide-1 (GLP-1) induce satiety (27). Active GLP-1 exists in
two equipotent forms, GLP-17-36 and GLP-17-37, although GLP-17-36 represents a majority of the
circulating active GLP-1 (34). GLP-1 is secreted within min of food ingestion and persists for
up to one h post-prandially (35). GLP-1 can suppress appetite (36), reduce energy intake (37),
and active GLP-1 is negatively associated with hunger and energy intake (31). Together, these
data support that these gut-derived hormones are important in appetite regulation and energy
intake. There is evidence that female sex hormones can influence AG (17,38) and GLP-1 (24)
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but it is not known whether fluctuations in E2 and P4 across the menstrual cycle can have an
effect.
To gain a more comprehensive understanding of the effect of menstrual cycle phase on
energy balance it is important to examine both energy intake and energy expenditure. Indeed, it
might be speculated that a change in energy expenditure could alter energy intake, or vice versa.
A number of studies indicate that 24-h energy expenditure can increase by as much as 89–279
kcal/day during the LP compared to the FP (13). Accordingly, increased sleeping metabolic rate
(39,40), basal metabolic rate (41), and 24-h energy expenditure (42,43) have all been reported
during the LP.

Thus, because energy expenditure and energy intake can fluctuate across

menstrual phases it is important to simultaneously collect these data from the same group of
females across a single menstrual cycle.
Changes in energy intake across the menstrual cycle are explained entirely by differences
in the caloric intake at each meal, as opposed to changes in the frequency of energy intake
(19,44).

Therefore, it seems reasonable to speculate that distinct post-prandial hormonal

responses would occur during each menstrual phase. For example, post-prandially AG might
decrease more rapidly or profoundly during the OP, thereby reducing perceptions of hunger and
energy intake in this phase. Therefore, the purpose of this project was to investigate fasting and
post-prandial AG and active GLP-1 concentrations throughout the menstrual cycle.

We

hypothesized that the LP, with increased P4, would be associated with greater concentrations of
AG, low active GLP-1, and a greater perceived hunger. During OP, with high concentrations of
E2, there would be lower AG but greater concentrations of active GLP-1, and a concomitantly
diminished perceived hunger. These results will provide important information on appetiteregulation in females.
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Methods
Participants. Eight healthy females volunteered to participate in the current project (age:
23.5±5.0 y; BMI: 24.15±3.15 kgm-2). Prior to study initiation, the experimental procedures and
potential risks were explained fully, and all participants provided written, informed consent. The
Wilfrid Laurier University Ethics Committee for Research on Human Subjects approved this
study.
Participants were between the ages of 18 and 35, recreationally active (exercising ≤3
sessions/wk), healthy, non-smokers, eumenorrheic for at least 1 y (regularly occurring menstrual
cycle lasting 24-35 d) based off self-reported menstrual history (23), menstruating for at least 3 y
(45), and had not been pregnant in the past 3 y nor were planning to become pregnant at the time
of data collection. Females were either non-hormonal contraceptive users for a minimum of 6
months or were using a tri-phasic hormonal contraceptive continuously for >1 y. Tri-phasic pills
suppress endogenous hormone production thereby providing a consistent and predictable
hormonal milieu while decreasing inter- and intra-variability in hormone concentrations (46).
Despite having far greater biological activity (up to 100X compared to natural forms) (47),
synthetic sex hormones in combined oral contraceptives produce a hormonal environment
similar to naturally fluctuating females (46). Moreover, tri-phasic contraceptives have been
included in past studies on appetite-regulating hormones (48,49) and various forms of oralcontraceptives do not affect food choice or energy intake (50,51). Participants provided a
detailed menstrual cycle history of at least the past three cycles. Day 1 of the menstrual cycle
was characterized by the onset of menses. Menstrual phase was subject-monitored by oral body
temperature taken upon awakening with a sustained increase of ~0.3 ºC identifying ovulation
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(23); participants reported their temperature each morning via email.

All phases were

subsequently confirmed by hormonal testing of fasting plasma E2 and P4 collected on study days.
Experimental Design. Participants had their hormonal concentrations and energy expenditure
measured during all three menstrual phases. Additionally, during each phase we assessed
perceptions of hunger, fullness, prospective energy intake, and food preference using visual
analogue scale (VAS). Each participant underwent a familiarization session before the first
experimental session followed by three experimental sessions (~3 h). During familiarization,
participants became accustomed with the respiratory mask, VAS, and blood sampling
procedures. Participant sessions were systematically rotated to minimize any order effects.
Participants were instructed to not engage in any strenuous physical activity for 48 h and
to refrain from caffeine and eating the morning of a session. Participants kept detailed food logs
24 h before all sessions such that energy intake could be replicated before subsequent sessions.
Participants arrived at the laboratory at 0800 h after an overnight fast (>10 h). Upon arrival,
participants were fitted with a respiratory mask that was worn continuously for 30 min.
Following gas collection, appetite was assessed using VAS. Immediately afterward, the first
blood sample was collected (0845 h) to test fasting hormone concentrations. After the first blood
sample participants were served a standardized breakfast (chocolate chip Clif bar, CA, USA; 29
kJkg-1 body weight) to be consumed within 15 min and were given 30 min for digestion. After
this, participants completed three VAS assessments immediately before blood samples collected
30 (0930 h), 60 (1000 h), and 90 min post-prandially (1030 h); similar sampling times have been
used in the past to determine changes in AG (32,33) and GLP-1 (52).
Gas Collection. Gas exchange was measured continuously for 30 min prior to eating. All gas
exchange measurements (VO2, VCO2, respiratory exchange ratio) were made using an online
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breath-by-breath gas collection and analysis system (Max II, AEI Technologies, Pittsburgh, PA,
USA).

Prior to data collection the gas analyzer was calibrated with gases of known

concentrations and flow with a 3-L syringe. All measures were collected while participants were
seated in a temperature-controlled room (~21 °C). The resting VO2 and VCO2 (Lmin-1) values
were averaged over the last 15 min of gas collection and used to determine the rates of fat and
carbohydrate oxidation. Resting metabolic rate (RMR) was estimated using total VO2 (Lmin-1)
over the final 15 min and an assumed relationship of 5 kcal per litre of O2. The following
stoichiometric equations were used with the assumption that protein oxidation was negligible
(53):
Fat oxidation (g/min) = 1.695 · VO2 (Lmin-1) · 1.701 · VCO2 (Lmin-1)
Carbohydrate oxidation (g/min) = 4.210 · VCO2 (Lmin-1) · 2.962 ·VO2 (Lmin-1)
Appetite Perceptions. Participants recorded perceptions of hunger, fullness, satisfaction, and
prospective EI using VAS (54). Responses were recorded upon arriving at lab (fasting) and
immediately before every blood draw. The VAS involved marking along a 100 mm line in
response to questions such as: “ How often do you eat breakfast in the morning?”; “How hungry
do you feel right now?”; “How full do you feel right now?”; “How satisfied do you feel right
now?”; and “How much food could you eat right now?”. The assessment of these questions
utilizing VAS has been validated (54) and used in past appetite research (55).
Blood Sampling. Two 3-mL venous blood samples were collected from an antecubital vein at
0845 h (#1; fasting), 0930 (#2; 30 min post-prandial), 1000 (#3; 60 min post-prandial), and 1030
h (#4; 90 min post-prandial) while participants were in the supine position. Blood samples were
collected into pre-chilled vacutainer tubes (BD vacutainer K2 ethylenediaminetetraacetic acid
[EDTA; lavender top]; Becton, Dickinson and Company, NJ, USA).

Inhibitors were
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immediately added for hormone preservation.

To preserve AG, 4-(2-Aminoethyl)

benzenesulfonyl fluoride hydrochloride was added (AEBSF; 10 µL per 1 mL of whole blood) to
the first vacutainer tube. To prevent inactivation of GLP-1, 10-µL of DPP-IV inhibitor and 500
KIU aprotinin per mL whole blood was added to the second vacutainer tube. Estradiol and
progesterone samples were analyzed from samples containing AEBSF, similar to past reports
(56-58).
All tubes were gently inverted ~10 times and centrifuged at 3000 rpm for 10 min at 4°C.
The plasma supernatant was then aliquoted into microcentrifuge tubes. To preserve AG, plasma
was acidified by the addition of 100 µL of 1 M HCl per mL plasma (50 µL). All samples were
stored at -80°C for subsequent analysis.
Biochemical Analysis. Commercially available enzyme-linked immunosorbent assays (ELISA)
were performed according to manufacturer recommendations to determine plasma concentrations
of AG (Cat. # EZGRA-88K, EMD Millipore, MA, USA), active GLP-1 (Cat. # EGLP-35K, EMD
Millipore, MA, USA), E2 (SKU: DCM003, Eagle Biosciencesm, Inc., NH, USA), and P4 (SKU:
DCM025, Eagle Biosciencesm, Inc., NH, USA). The acylated ghrelin assay was specific for
measuring the active (acylated) form of this peptide in human serum or plasma with no cross
reactivity with inactive (des-acyl) ghrelin. The active GLP-1 assay was specific for measuring
the two active forms of this peptide (GLP-17-36 and GLP-17-37) in human plasma with no cross
reactivity (<3%) with other forms of GLP-1 (i.e. GLP-11-36, GLP-11-37, GLP-19-36, GLP-19-37).
Estradiol assay had no cross reactivity (<2%) with other forms of estrogen and the progesterone
assay did not cross react with testosterone (<1%) or other progesterones (<1%).

To eliminate

inter-assay variation, samples from each participant were analyzed in the same run. Samples
were run in duplicate to reduce intra-assay variation. The intra-assay coefficient of variation was
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8.41±5.66 for AG, 11.07±8.29 for active GLP-1, 6.01±5.82 for E2, and 5.16±5.93 for P4; all were
below the accepted standard of detection for each kit.
Statistical analysis. Data were analyzed using SPSS software version 22.0 for Windows (SPSS,
Chicago, IL). One-way repeated measures ANOVA were used to compare body weight, fat and
carbohydrate oxidation, resting metabolic rate, and respiratory exchange ratio (RER) across
menstrual phases. One-way repeated measures ANOVA were performed to compare fasting AG
and active GLP-1 concentrations across menstrual phases. To calculate the relative change in
hormones, data were normalized to baseline values and analyzed as change from fasting. To
compare the changes of AG and active GLP-1, 4 x 3 repeated measures ANOVA (time x phase)
were performed. Absolute AG and GLP-1 concentrations were also analyzed but the same
results were found so for clarity only relative change data will be reported.

Hormone

concentrations were used to calculate area under the curve (AUC) using the trapezoidal method
(59) and these AUC values were compared using one-way ANOVA across menstrual phases.
Perceptions of appetite were also normalized to baseline and analyzed with 4 x 3 repeated
measures ANOVA (time x phase). All tests were performed separately on oral-contraceptive
users and naturally cycling females and similar trends were observed. Where significant main
effects were found, post-hoc analysis using a Bonferroni correction for multiple comparisons
was performed.

Statistical significance was set to p < 0.05.

All data are presented as

mean±standard deviation.
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Results
Participants. Participant body weight did not change (P=0.249) across menstrual phases (Table
1).

Participants all reported regularly eating breakfast in the mornings (80±9 mm) and

successfully replicated energy intake the day before all sessions (FP: 1442.8±540.7 kcal, OP:
1492.8±671.15, LP: 1582.6±314.7).

Three participants were currently using tri-phasic oral

contraception (Tri-cyclen lo, Janssen Pharmaceuticals, ONT, Canada) for >1 y and maintained
usage throughout the study while the other 5 participants had not been using any form of
hormonal birth control for >1 y prior to participation.

Table 1: Participant characteristics. Note: unlike letters represent
significant differences (P<0.05).
Follicular
Ovulatory
Luteal
Phase
Phase
Phase
Session day
4.0±1.0
9.4±1.1
23.2±1.6
Body weight (kg)

63.9±15.3a

63.3±14.5a

63.4±15.2a

Body temperature (°C)

36.2±0.1a

36.2±0.1a

36.7±0.1b

E2 (pgmL-1)
P4 (NgmL-1)

26.92±15.58a 180.26±53.07b
1.39±1.48a

0.90±0.50a

98.08±17.67c
43.05±14.79b

Body temperature indicated that ovulation had occurred in the non-contraception using
females prior to the LP session (Table 1); body temperature was significantly elevated during the
LP compared to FP (P=0.030) and OP (P=0.034).

Moreover, fasting plasma E2 and P4

concentrations (Table 1) confirm proper timing of testing sessions and are in accordance with
accepted concentrations for E2 and P4 during all menstrual phases (Eagle Biosciences, Inc., NH,
USA). E2 was elevated during the OP compared to both the FP (P=0.003) and LP (P=0.024); E2
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was also elevated in the LP compared to the FP (P=0.001). P4 was elevated during the LP
compared to both the FP (P=0.004) and OP (P=0.005); P4 was similar during the FP and OP
(P=0.306).
Appetite-Regulating Hormones. There was no difference in the fasting concentrations of AG
across the menstrual phases (P=0.848, ηp2=0.023). There was no effect of menstrual cycle phase
(P=0.959, ηp2=0.006) or phase x time interaction (P=0.433, ηp2=0.126) on the post-prandial
change in AG.

There was a main effect of time (P=0.008, ηp2=0.424) such that AG

concentrations were decreased 30 (P=0.042), 60 (P=0.014), and 90 min post-prandially
(P=0.034) compared to fasting (Figure 1). There was no difference (P=0.185, ηp2=0.214) in the
AG AUC.
Figure 1: (A) Relative change from baseline and (B) AUC of AG during each menstrual
phase. No significant differences were found between phases. Note: * - indicates significantly
lower relative to fasting (P=0.008); AG – acylated ghrelin; AUC – area under the curve. All
data presented as mean±SD.
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Figure 2: (A) Relative change from baseline and (B) AUC of active GLP-1 during each
menstrual phase. No significant differences were found between phases. Note: * indicates significantly elevated relative to fasting (P=0.027); AG – acylated ghrelin; AUC
– area under the curve. All data presented as mean±SD.

There was no difference in the fasting concentrations of active GLP-1 across the
menstrual phases (P=0.567, ηp2=0.051). There was no effect of menstrual cycle phase on the
relative change in active GLP-1 from fasting (P=0.650, ηp2=0.06) or a phase x time interaction
(P=0.398, ηp2=0.069). There was a main effect of time (P=0.027, ηp2=0.483) where active GLP1 was elevated 30 (P=0.021) and 60 min post-prandially (P=0.043), but not 90 min postprandially (P=0.051) compared to fasting (Figure 2).

There was no difference (P=0.605,

ηp2=0.069) in active GLP-1 AUC.
Appetite Perceptions. There was no effect of menstrual cycle phase (P=0.263, ηp2=0.174) or
phase x time interaction (P=0.241, ηp2=0.179) on perceptions of hunger but there was a main
effect of time (P=0.001, ηp2=0.660) (Figure 3A). Perceived hunger was lower 30 (P=0.001), 60
(P=0.002), and 90 min post-prandially (P=0.012) compared to fasting. There was a main effect
of phase (P=0.048, ηp2=0.351) and time on perceived fullness (P<0.001, ηp2=0.693), but no
phase x time interaction (P=0.1, ηp2=0.262). The main effect of phase showed that fullness was
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greater during the OP compared to the FP (P=0.02) and approached significance in the LP
(P=0.06). The main effect of time showed that fullness was greater 30 (P<0.001), 60 (P=0.001),
and 90 min post-prandially (P=0.009) compared to fasting (Figure 3B). For satisfaction there
was a main effect of time (P<0.001, ηp2=0.784) but no effect of phase (P=0.263, ηp2=0.174) or
phase x time interaction (P=0.235, ηp2=0.167). Satisfaction was increased 30 (P<0.001), 60
(P=0.001), and 90 min post-prandially (P=0.002) compared to fasting (Figure 3C).
Figure 3: Changes in (A) perceived hunger, (B) satisfaction, (C) fullness, and (D) prospective
energy intake during each menstrual phase. Note: * - indicates significantly different than
fasting (P<0.05). All data presented as mean±SD.

38

For prospective energy intake, there was no effect of menstrual cycle phase (P=0.725, ηp2=0.045)
or phase x time interaction (P=0.110, ηp2=0.210) but there was a main effect of time (P<0.001,
ηp2=0.705) (Figure 3D). Prospective energy intake was decreased 30 (P<0.001), 60 (P=0.001),
and 90 min post-prandially (P=0.002) compared to fasting (Figure 3D). There was no difference
in anxiety or nausea between phases (P>0.05; data not shown).

Table 2: Resting metabolic rate, RER, and substrate oxidation. No significant differences were found.
Follicular Phase

Ovulatory Phase

Luteal Phase

Resting metabolic rate (kcal)

1381±297

1399±330

1421±378

Respiratory exchange ratio

0.92±0.07

0.88±0.04

0.91±0.04

Carbohydrate oxidation (gmin-1)

0.17±0.05

0.14±0.04

0.16±0.04

Fat oxidation (gmin-1)

0.03±0.03

0.04±0.02

0.03±0.02

Resting Metabolic Rate, RER, and Substrate Oxidation. There was no effect of menstrual cycle
phase on resting metabolic rate (P=0.961, ηp2=0.006), RER (P=0.399, ηp2=0.123), carbohydrate
oxidation rate (P=0.603, ηp2=0.07), or fat oxidation rate (P=0.485, ηp2=0.098) (Table 2).

Discussion
The present study was designed to explore the effect of female menstrual cycle phase on
appetite-regulating hormones, resting metabolic rate, and perceptions of appetite.

We

hypothesized that appetite-regulating hormones and perceived appetite would fluctuate
throughout the menstrual cycle in conjunction with female sex hormones. The main findings of
this project are: (a) menstrual cycle phase had no effect on AG or active GLP-1, (b) post-prandial
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fullness was greatest during the OP, and (c) resting metabolic rate and substrate oxidation were
unaffected by menstrual phase. These results indicate that AG and GLP-1 are not responsible for
changes in energy intake across the menstrual cycle.
We did not observe any effect of menstrual cycle phase on the concentrations of AG,
similar to past reports (57,58,60). Estradiol is believed to reduce energy intake by reducing the
quantity of food consumed at each meal (13,61), suggesting that the post-prandial hormonal
response to energy intake would be different in conjunction with varying E2 concentrations (e.g.
a more profound decrease in post-prandial AG during the OP, thereby reducing hunger and
energy intake, compared to the LP). We are the first to measure the post-prandial change in AG
across the menstrual cycle and our data do not support this idea, nor are what would be expected
when considering the consistent fluctuations in energy intake across the menstrual cycle (9-12).
Therefore, our data extend on past work to show that fluctuations in sex hormones across a
typical menstrual cycle do not affect AG or the post-prandial change in AG.
Similar to AG, there was no difference in active GLP-1 across menstrual phases. Only
one other report has examined the effect of menstrual phase on GLP-1 and found that total GLP1 concentrations were lower in the FP compared to the LP because of slowed gastric emptying
during the FP (24). In contrast, our current results found no differences in the active form of
GLP-1, suggesting that active and total forms of GLP-1 might be differently affected by female
sex hormones.

However, our data suggest that active GLP-1 is unlikely to be altered by

menstrual phase or female sex hormones and therefore unlikely to explain the previously
observed changes in energy intake.
Interestingly, we did find that perceived fullness was greater during the OP compared to
LP, although perceived hunger and prospective energy intake were similar. These findings could
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be produced by the elevated E2 concentrations observed during the OP phase and would be in
line with the reduced energy intake from past literature. (10,11,44). Additionally, although
statistically insignificant, 30 min post-prandial hunger appeared to be reduced to a greater extent
during OP (-50%) compared to both the FP (-27%) and LP (-33%). To our knowledge this is the
first study to investigate these perceptions across the menstrual cycle. Our similar hormonal
profiles in conjunction with the different perceptions of appetite imply that central mechanisms
could account for the changing energy intake across the menstrual cycle. Perhaps E2 and P4
influence neuronal control of energy intake within the arcuate nucleus (ARC) such that similar
hormonal concentrations lead to different perceptions of appetite. But given that perceived
hunger and fullness correlate with actual energy intake (31) the current differences warrant
future investigation.
In light of the current data, it seems that production of AG and active GLP-1 are not
responsible for the changes in energy intake that occur throughout the menstrual cycle. Indeed,
our work supports that the sensitivity to these hormones is changing, as has been demonstrated
for other appetite-regulating hormones, such as cholecystokinin (19), total ghrelin (7), and leptin
(62,63). Sensitivity to gut hormones would likely occur within the ARC as it is responsible for
integrating hormonal signals to control energy intake (27). Both NPY/AgRP and POMC/CART
neurons within the ARC possess abundant E2 receptors (62-65). Similarly, prolonged (28 d) P4
treatment up-regulated NPY and down-regulated CART genes (both of which would be expected
to stimulate EI) (66).

Altered sensitivity would explain why we found similar circulating

hormone concentrations but different perceptions of fullness across menstrual phases.
Finally, we observed no difference in substrate oxidation or RMR across menstrual
phases. While previous studies demonstrated a slightly elevated RMR during the LP phase (39-
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43), the present data illustrates no differences across phase. However, RMR can be increased
from 2.5-11.5% during the LP compared to the FP, and the current data is within this range,
despite being statistically insignificant. Similarly, fat oxidation rate was increased during the OP
(0.04 gmin-1) compared to the FP and LP (both 0.028 gmin-1) as we would expect when E2
concentrations are elevated (67), although this was also statistically insignificant. Our small
sample size likely contributes to our inability to detect the small differences that occur across
menstrual phases.
An important limitation to the current project is that we had participants arrive at 0800
and assessed appetite-regulating hormones over ~2.5 h although there are circadian rhythms
associated with female sex hormones. Specifically, P4 concentrations decrease throughout the
day and E2 concentrations might decrease post-prandially (68) meaning we may have missed
peaks or nadirs in female sex hormones. Future work should extend on the current project by
measuring at different times of day and sampling hormones over longer fasting and post-prandial
time periods. Moreover, we fed participants identical test meals (29 kJkg-1 body weight).
Considering the amount consumed at each meals is responsible for the changes in energy intake
observed throughout the menstrual cycle (44) further research should test post-prandial hormonal
responses to meals of various caloric content and even macronutrient composition. Additionally,
we measured only two appetite-regulating hormones, but there is evidence that others could be
important, including cholecystokinin (69), leptin (18), and insulin (15). We also had a relatively
small sample size and all females were young and normal weight. We intentionally collected on
normal-weight females as body composition can attenuate the post-prandial rise in GLP-1 and
fall ghrelin (70). In light of the particular challenge overweight females have with managing
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body weight and their propensity to progress into obesity future research will need to confirm the
present findings in overweight and obese females.
Conclusion
The current project was designed to test the effects of female menstrual cycle phase on
appetite-regulating hormones and perceived appetite. We show that fasting and post-prandial
AG and active GLP-1 are unaffected by female menstrual cycle phase. Given the difficulty
females experience with weight management it is important to continue exploring potential
mechanisms of appetite and energy intake regulation. In light of accumulating research, future
work should investigate the effects of menstrual cycle phase on neuronal control of appetite and
energy intake and their sensitivity to circulating hormones since we show that gut-derived
hormones are unaffected.
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Chapter 3

General Discussion
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The current project was designed to examine whether the changes in estradiol and
progesterone across the menstrual cycle are related to changes in appetite-regulating hormones
and perceptions of appetite. Our results demonstrate that menstrual cycle phase has no effect on
AG or active GLP-1 but fullness was greatest during the OP.

These data show that the

concentrations AG and active GLP-1 are not responsible for the fluctuating energy intake across
the menstrual cycle and suggest other mechanisms are affecting appetite.
We did not observe any effect of menstrual cycle phase on the concentrations of AG,
similar to past reports (1-3). Importantly the circulating concentrations in the current project are
similar to those reported in other studies (4-6). In light of previous research showing that
estradiol can influence the production of ghrelin it is possible that the estradiol fluctuations
across a normal menstrual cycle are not great enough to affect ghrelin production. Indeed, the
human study showing that estradiol affects ghrelin production was in amenorrheic females who
express diminished estradiol and progesterone concentrations (7) making it difficult to
extrapolate the results to a healthy eumenorrheic population. Based on the current AG data, to
detect a 20% difference in AG with 80% power, we would require 152 participants, reflecting
that any potential difference is small and unlikely to explain the changing energy intake. Finally,
we performed Pearson correlations between fasting AG and estradiol concentrations to see if we
missed any possible relationships. The only significant relationship was an inverse correlation
between AG and estradiol during the LP (r=-0.764, P=0.027). This result is interesting but
difficult to reconcile with the other results showing that AG concentrations did not differ across
menstrual phases. There were no significant correlations between progesterone and AG. We
found moderate correlations between AG and perceptions of hunger at 30 (r=0.584, P=0.003), 60
(r=0.481, P=0.021), and 90 min post-prandially (r=0.647, P=0.001), as would be expected based
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off of past literature (8). Our current results support previous work demonstrating that sex
hormone fluctuations across the menstrual cycle do not affect ghrelin making it unlikely to
explain the changes in energy intake.
Only one previous study examined the effect of menstrual phase on GLP-1 and found that
total GLP-1 concentrations were lower in the FP compared to the LP (9). Contrary to this we
found no difference in the active forms of GLP-1. The reasons for our conflicting results are
unclear, but participants in the previous study were fed only 50 g glucose dissolved in 300 mL
water (200 kcal) (9). Importantly, GLP-1 has important incretin effects, specifically inducing
insulin secretion and glucose uptake by skeletal muscle and adipose tissue (10). Thus, a dose of
glucose compared to a meal replacement, as in the current report, with ~0.2 g/kg of fat and ~0.5
g/kg protein content, might be expected to produce a different incretin hormonal response due to
slower digestion and lower glycemic load. With the current GLP-1 data, to detect a 20%
difference in active GLP-1 with 80% power, we would require 30 participants, suggesting that
any difference is quite small. The current concentrations of active GLP-1 are slightly greater
than that previously observed (11) but very few studies have examined this form of GLP-1.
When we performed correlations between estradiol and active GLP-1, we observed significant
correlations during the OP (r=0.752, P=0.031), LP (r=0.816, P=0.013), and approached
significance during the FP (r=0.696, P=0.055). We found no significant correlations between
GLP-1 and progesterone. We observed no significant correlations between active GLP-1 and
perceptions of fullness. However, a past study found that GLP-1 only correlated with fullness
during the late phase of satiety (60-180 min post-prandial), thus our more acute study might miss
this relationship. Taken together, we show that active GLP-1 is unaffected by menstrual phase.
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The only observed difference in the current report is that post-prandial fullness was
greater during the OP compared to FP and approached significance in the LP. This result is
interesting given that females consume less food during the OP (12). Importantly, this occurred
in conjunction with increased estradiol concentrations, reflecting estradiol’s anorexigenic
properties (13,14). At the same time, although it was statistically insignificant, post-prandial
hunger appeared to be suppressed to a greater extent during the OP compared to both the FP and
LP.

This result makes sense given the greater fullness, but nevertheless aligns with our

hypothesis. However, there was no correlation between fasting estradiol concentrations and
perceptions of hunger (r=-0.198, P=0.353) or fullness (r=-0.05, P=0.816).

We saw no

differences between perceptions of appetite during the LP, implying that progesterone is not
producing an orexigenic effect during this phase.

This was supported by no apparent

correlations between progesterone and fasting hunger (r=0.046, P=0.832) or fullness (r=0.165,
P=0.441). AG and GLP-1 concentrations were similar meaning these cannot explain the altered
appetite we observed during the OP.

However, altered sensitivity to appetite-regulating

hormones, other appetite-regulating hormones such as CCK and leptin, or the circadian rhythms
of estradiol and progesterone could all be contributing the current results.
The current report did not observe any difference in energy intake, as assessed by selfreport food logs, across the menstrual cycle. When assessed as absolute kcal there was no
difference in the average 48 h energy intake across sessions (P=0.850, ηp2=0.010) (Table 2). We
also found no difference in the consumption (grams) of protein (P=0.51, ηp2=0.048), fat (0.357,
ηp2=0.071), or carbohydrate (0.283, ηp2=0.086) (Table 2). When analyzed as kcal/kg body
weight the same results were observed.

This is opposed to numerous reports (12,15-17)

demonstrating that energy intake increases by up to 90-500 kcal/day, or an increment of 3.952

34.7%, during the LP compared to the FP (18). Although this difference is certainly capable of
altering energy balance and body weight, it is a relatively small change to try and detect with
food logs. People regularly underreport energy intake by ~25-50% (19) making it unsurprising
that we were unable to detect a change that may be as little as 3%. Unfortunately, adherence to
food reporting was poor (only 4 of 8 participants completed all 3 phases) and there was evidence
of under reporting for the current report forcing us to remove this data from the manuscript. This
is not uncommon as up to 72% of females underreport food intake (20,21) by as much as ~25%
(20,21,22). Fluctuations in energy intake during the menstrual cycle are generally accepted so
our current results are very likely due to our collection methods.
We did not detect any differences in resting metabolic rate or substrate oxidation despite
numerous past reports demonstrating significant differences in energy expenditure across the
menstrual cycle (23-25). Although the reason for this is unclear, our small sample size could
contribute. As previously mentioned, the differences detected are generally quite small, ~8%
(23), and are detected over long periods of time. Considering the current data (0.94±0.19
kcal/min), to detect an 8% difference in energy expenditure with 80% power, we would require
204 participants, affirming the small differences that exist across menstrual phases. However,
because energy expenditure and energy deficits are important factors in the regulation of
appetite-regulating hormones and perceived appetite (11,26), the current data does allow us to
say that energy expenditure was not a confounding factor for hormonal concentrations or
perceptions of appetite in the current report.
Limitations and Future Directions. It is important to recognize that this project explored only a
small set of appetite-regulating hormones and that estradiol can influence other appetiteregulating hormones, such as CCK, leptin, and insulin. CCK is a satiety-inducing hormone and
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there is evidence that estradiol increases its potency (14). It is not clear exactly how estradiol
enhances the potency of CCK, but there is a site of interaction within the hypothalamus so it is
possible that ARC neurons play a role (27). At the same time, leptin and insulin are important
signals capable of reducing energy intake and are both influenced by estradiol (28). Much like
CCK, the anorexigenic effect of leptin appears to be enhanced in the presence of estradiol.
Eating was reduced more substantially in female rats compared to males when leptin was infused
directly into their brains, an effect that was attributed to the anorexigenic potency of leptin being
enhanced by estradiol (29). A potential mechanism for this is again the colocalization of leptin
and estradiol receptors on NPY/AgRP and POMC/CART neurons (30).

Finally, there are

important sites of interaction between estradiol and insulin, including on NPY/AgRP and POMC
neurons (31). Therefore, future projects will need to consider all of these possible interactions
and test concentrations of hormones and neuropeptides across menstrual phases before we can
conclusively say why energy intake consistently changes.
In light of the current data, it seems that the gut-derived hormones AG and active GLP-1
are not responsible for the changes in energy intake that occur throughout the menstrual cycle.
However, changing sensitivity to these hormones still remains a viable explanation (29,32-34).
Altered sensitivity to gut hormones likely occurs in the ARC given that both NPY/AgRP and
POMC/CART neurons possess abundant E2 receptors. Thus, E2 might exerts it anorexigenic
effect directly on the neurons that regulate energy intake (13,33,35,36). At the same time, upregulated NPY and down-regulated CART genes (both of which would be expected to stimulate
EI) were observed when female rats were treated with progesterone for 28 days (37). Taken
together, these data implicate the ARC in the modulation of energy intake in response to
fluctuations in female sex hormones throughout the menstrual cycle.
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Historically the ARC was thought to be the key site for regulating energy intake, but it is
now recognized that a broader neural network, including the fusiform, amygdala, hippocampus,
and dorsal striatum contributes to the regulation of energy intake (32). Research is beginning to
use brain-imaging techniques (e.g. fMRI) to explore how different brain regions respond to food
intake or food images and has produced interesting results that are relevant to the current project.
For instance, food images produced greater activation of lateral and dorsolateral prefrontal
cortex, and parietal cortex in females compared to males (38).

Moreover, food pictures

activated the lateral orbitofrontal cortex, prefrontal cortex, hippocampus, amygdala, and fusiform
of females scanned around ovulation, whereas only the fusiform was activated in the LP (32).
These results likely reflect that numerous brain regions possess estrogen receptors (39) which
could make them susceptible to the fluctuations in female sex hormones associated with the
menstrual cycle. Taken together, these data suggest that the effects of female sex hormones are
highly complex and can influence appetite and energy intake through various central
mechanisms.
One important factor that must be addressed in future research on the menstrual cycle is
how to accurately and easily monitor menstrual phase. A recent report used ultrasound scans of
participants’ ovaries every morning over a one month study (1) thereby affording great accuracy
but high burden on researchers and participants. The current project used a combination of body
temperature, similar to other reports (40,41), and predicted menstrual cycle days based off of
menstrual history. Although this is a convenient method, the pre-ovulatory estradiol surge is
particularly difficult to monitor and predict. Even the use of ovulation kits would not have been
helpful as those measure the estradiol-induced surge in luteinizing hormone.

Indeed, the

menstrual cycle is inconsistent and can be perturbed by many factors (e.g. stress and exercise)
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making it difficult to predict. Furthermore, up to 12% of menstrual cycles can be anovulatory in
young healthy females (42). Anovulatory cycles are asymptomatic and produce diminished
concentrations of both estradiol and progesterone during the LP (42) which will distort the
conclusions of research on the menstrual cycle. Finally, although the current project divided the
menstrual cycle into three phases, it is possible to do this differently. For instance, others divide
it simply into pre- and post-menstrual phases (12) or into early follicular (days 1–4), late
follicular (days 5–11), periovulation (days 12–15) and the luteal phase (days 16–28) (18).
Together these issues exacerbate the complexity of conducting research on female physiology,
especially research on the menstrual cycle.
Another potential confounding factor is our use of participants using tri-phasic hormonal
contraceptives.

Tri-phasic pills suppress endogenous hormone production (43) as can be

observed by the low concentrations of estradiol and progesterone in the three participants using
pills during the current project (see Appendix VI). However, tri-phasic pills, such as the one
used by our participants, contain changing doses of an estrogen and progesterone and, so long as
pills are taken as directed, produce a hormonal environment similar to a normal menstrual cycle
(43). Indeed, authors of this study concluded that tri-phasic pills represent an ideal research tool
for investigating the effects of ovarian hormones (43). To confirm that the current results were
the same in non-oral contraceptive using participants we performed a 4 x 3 ANOVA (time x
phase) on the relative chance in AG and active GLP-1 in only these five participants. As
expected, there was no effect of phase or phase by time interaction on AG (P=0.659 ηp2=0.055,
P=0.835 ηp2=0.102, respectively) or active GLP-1 (P=0.313 ηp2=0.252, P=0.547 ηp2=0.175,
respectively).

Therefore, it is unlikely that the inclusion of participants using tri-phasic
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contraception skewed our data and suggests that it could be beneficial for future research to
include only tri-phasic pill users to monitor menstrual phase.
Conclusions. Until 1993, when the NIH mandated the inclusion of females in clinical research,
most physiological research had been performed on males (44). Until this time, the primary
function of female sex hormones was believed to be the creation of a hospitable environment for
conception and fetal development (44). Gradually, it is becoming clear that females require
unique research. This seems logical given that females experience unique hormonal fluctuations
that likely have important physiological effects. Despite research beginning to appreciate the
numerous functions of female sex hormones, when reviewing literature on the effects of exercise
on appetite-regulating hormones there are 43 studies that looked at only male participants, 12
studies included males and females, five were females only, but of all the studies on females,
only two controlled for menstrual phase; although they were only during early FP when both
estradiol and progesterone are at their lowest concentrations (4,45).

Together, these

considerations make it important that research such as the current project continue to be
performed.
We chose to focus on appetite-regulation given the changes in cravings and energy intake
across the menstrual cycle (12,46). Ultimately, females are probably in a battle against biology
and evolution. Given that small energy deficits can have detrimental effects on reproductive
health and that females require a relatively high percentage of body fat to experience regular
menstrual cycles, it is conceivable that numerous redundant mechanisms exist to ensure that
females tightly maintain fat stores and energy intake. Indeed, central (e.g. various brain regions)
and peripheral (e.g. numerous appetite-regulating hormones) mechanisms likely all contribute to
the regulation of energy intake in females. The current report found that two gut-derived
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hormones (AG and active GLP-1) are not responsible for the difference in energy intake across
the menstrual cycle but we did find that perceptions of appetite differ across menstrual phases.
We have proposed other mechanisms that warrant investigation to eventually contribute to our
understanding of female weight management.
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Appendix I – Visual Analogue Scale

Participant Code: ________________________

Date: _____________

Session: __________________________________

Question 1: How often do you eat breakfast in the morning?
Never

Every morning

___________________________________________

Question 2: How hungry are you right now?
Not hungry at all

Very hungry

___________________________________________

Question 3: How full do you feel right now?
Not full at all

Very full
___________________________________________

Question 4: How much do you think you could eat right now?
Nothing at all

A lot

___________________________________________
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Question 5: How anxious are you right now?
Not anxious at all

Very anxious

___________________________________________

Question 6: How nauseated are you right now?
Not nauseated at all

Very nauseated

___________________________________________
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Appendix II – Daily Food Log
Instructions:

1. Record all food intake for a 3 day period (day before session, day of session, day after
session)
2. Try to consume foods that you would typically eat as part of your regular diet.
3. Keep your recording sheets with you at all times. (Snacks are typically consumed
unpredictably and, as a result, it is impossible to record them accurately unless your
recording forms are nearby.)
4. Use a small food scale if you have one or standard-measuring devices (measuring cups,
measuring spoons, etc) to record the quantities consumed, as accurately as possible. If
you do not eat all of the item re-measure what’s left and record the difference.
5. Record combination foods separately (i.e., hot dog, bun, and condiments) and include
brand names of food items (list contents of homemade items) whenever possible.
6. For packaged items, use labels to determine quantities.

Example:

Time of Day
(i.e. 8:15 am,
12:30 pm)

Food Item (include
brand name if
possible)

Quantity
(i.e. g, mL,
cups, etc.)

9:30 am

Eggs

2 whole

9:30 am
10:15 am
11:05 am
1:50 pm

Egg whites
Tropicana orange juice
Apple
Dominos Pizza

½ cup
1 cup
1 whole
4 slices

1:50 pm

Pepsi

500 ml

Notes
(i.e. ingredients &
amounts used if
possible)
½ tsp salt, ½ cup
cheese, ½ tsp butter
Pepperoni, mushroom,
cheese
-
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DAY 1 (day before session)

Time of Day
(i.e. 8:15 am,
12:30 pm)

Food Item
(Include brand name if
possible)

Date: ___________

Quantity
(i.e. g, mL,
cups, etc.)

Notes
(i.e. ingredients &
amounts used if
possible)
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Appendix III – Study Recruitment Poster

FEMALES NEEDED FOR
APPETITE REGULATION
STUDY
(REB #4598)

What is Appetite Regulation?
Ø Various hormones control how much we eat
Ø The female menstrual cycle may alter these hormones
Purpose:
Determine whether the hormones associated with the menstrual cycle alters the
hormones that control food intake

Study details:
Ø Each session involves 4 blood samples taken from the arm
Ø In order to participate you must be:
o Female, 18-35 years of age
o Regularly menstruating
o Non-hormonal contraceptive user (or using tri-phasic pill, such as: Ortho
Tri-Cyclen, Enpresse, and Ortho-Novum 7/7/7)
o Healthy and exercise ≤3 per week
o Non-smoker
Ø Time commitment:
o 3 sessions of ~3 h (9 hrs total)
o Sessions will be over 1 menstrual cycle (~1 month)
Benefits of participating:
Ø Learn and contribute to the better understanding of female physiology
Ø Three free meals!
If interested please contact:
Logan Townsend, M.Sc. student – town9000@mylaurier.ca
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Appendix IV – Ethics

CONSENT TO PARTICIPATE IN RESEARCH
LETTER OF INFORMATION

Date:
Title of Study: The Effect of Menstrual Phase on Energy Regulating Hormones in Response to SprintInterval Training (REB #4598)

Dear ______________________________:
You are being invited to participate in a research study conducted by Tom J. Hazell (PhD), Hashim Islam
(BSc Kin), and Logan Townsend (BA Kin) from the Energy Metabolism Research Laboratory.
In order to participate it is important you are: a) between 18-30 year old, b) recreationally active <3/wk,
c) healthy, d) normally menstruating, e) either using no form of hormonal contraceptive or using a triphasic pill as this project is designed to determine how these hormones influence appetite hormones.
PURPOSE OF THE STUDY
The primary purpose of this study is to examine the effects of acute sprint interval training on energy
expenditure and hormones that regulate energy intake in women and how the menstrual phase may
influence this in order to determine potential fat loss mechanisms.
PROCEDURES
This study requires you to visit the Energy Metabolism Research Laboratory 3 separate times, one for a
familiarization session (<30 min) and then for 2 testing sessions (~4.5 h) for a total time commitment of
~9 hours. All experimental sessions (separated by 96 h) will include a standardized breakfast and 30 min
exercise session (7 min warm-up, 18 min SIT exercise, and 5 min cool-down) followed by a 3 h postexercise measure of gas exchange where participants rest comfortably and quietly in the laboratory (i.e.
reading). Blood samples will also be drawn from the forearm pre- and post-exercise (4 samples total).
Blood draws will be taken from the inner elbow while seated by a trained researcher; all equipment will
be sterile one-time use. Blood draw site will be cleaned prior to each sample and researcher will wear
clean gloves to ensure cleanliness. The exercise will involve traditional SIT characterized by 4 bouts of 30
sec "all-out" efforts followed by 4 min rest/active recovery (i.e. light walking). The exercise session
includes only 2 min of work and 16 min of rest/recovery. You will also be asked several questions before
and after exercise to determine your feelings of hunger and satiety. You will be asked to record dietary
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intake the day before the trail, on trial day and the day after. You will also be required to give a detailed
history of your menstrual cycle, including length of recent cycles, when you began menstruating, and if
you have ever had irregular menstrual cycles.
POTENTIAL RISKS AND DISCOMFORTS
We appreciated that this study requires you to discuss highly personal and sensitive information and we
will do our best to make you as comfortable as possible; should you feel uncomfortable at any point you
are free to withdraw from the study. All information regarding the menstrual cycle is only used to
ensure that our testing days are done at the appropriate times, this information will not be included in
any publications or presentations and the participant will not be identifiable by the information the
provide. There is a possibility of mild muscle soreness and/or fatigue typical of an exercise session. You
may feel some discomfort due to the intensity of the training typical of strenuous physical exertion, as
you are required to perform the training and testing sessions with maximal effort. Although phlebotomy
is safe when done by certified and training individuals there is a small risk of bruising at the puncture
site which can be reduced by keeping pressure on the site for several minutes after the needle is
withdrawn. In some rare cases the vein may become inflamed after the sample is withdrawn however
using a warm compress can alleviate this. There is a small risk of infection any time the skin is broken
however this rarely occurs when equipment is properly sterilized and disposed of. Some people may
also experience light-headedness if they are uncomfortable with needles and if this occurs the
experiment will be terminated immediately. The risk of falling if this occurs is minimum as the
participant will be seated in a secure phlebotomy chair.
POTENTIAL BENEFITS TO SUBJECTS AND/OR SOCIETY
The potential benefits of your participation in this study include an improvement in your exercise
capacity using a novel, time-efficient training modality as well gain a better understanding of your
cardiorespiratory fitness. Results from this study will further our understanding of high-intensity interval
training and its effects on energy expenditure as well as participant’s feelings towards these
modifications of this intense form of training.
CONFIDENTIALITY
All information obtained in connection with this study will be de-identified. All contact information is
collected and stored on a master list in a password-protected file with access to only the study
investigators. All participants will be assigned an arbitrary number to ensure anonymity. This study
number will be used in all data collection files and mean data will be stored in a password protected file
for comparison with future studies. Raw data will not be released to any other parties and all results will
be collapsed before analysis. All blood samples will be stored in a secured location until analysis and
subsequently destroyed.
PARTICIPATION AND WITHDRAWAL
Your participation in this research study is completely voluntary. If you are a student and volunteer to
be in this study, you may withdraw at any time without any effect on your status at Wilfrid Laurier
University. If you are not a student, you may withdraw at any time. You may also refuse to answer any
questions you feel are inappropriate and still remain in the study. The investigators may withdraw you
from this research if circumstances arise which warrant doing so (i.e. lack of effort during exercise
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sessions, difficulty scheduling, repeatedly missing scheduled sessions, etc.). Please note that should you
withdraw from the study all personal information and blood samples will be immediately destroyed.
FEEDBACK OF THE RESULTS OF THIS STUDY
If you would like a copy of a lay summary of the results please check the box below. The results from
this study will be reported in general terms in the form of speech or writing that may be represented in
manuscripts submitted for publication in scientific journals, or oral and/or poster presentations at
scientific meetings, seminars, and/or conferences. We plan to publish this study in an academic journal.
The information published in a journal or subsequent studies will not identify you in any way. Copies
will be available upon request.

SUBSEQUENT USE OF DATA
This de-identified data may be used in subsequent studies (with no link to your personal information).
You will receive a copy of the consent form after it has been signed and do not waive any legal rights by
signing it.
-----------------------------------------------------------------------------------------------------------This letter is yours to keep. If you have any questions about this research project feel free to call:
Dr. Tom Hazell 519-884-1970 x3048
Further, if you have any questions about the conduct of this study or your rights as a research subject
you may contact Dr. R. Basso, Research Ethics Board (REB) Chair (rbasso@wlu.ca / 519-884-0710 x4994).
Sincerely,
Logan Townsend (town9000@mylaurier.ca), MSc Student
Hashim Islam (isla9020@mylaurier.ca), MSc Student
Dr. Tom Hazell (thazell@wlu.ca), Assistant Professor
Department of Kinesiology and Physical Education, Wilfrid Laurier University, Waterloo, ON
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Title of Study: The Effect of Menstrual Phase on Energy Regulating Hormones in Response to SprintInterval Training (REB #3862)

Consent Statement
Principal Investigators: Dr. Tom Hazell
I have read the accompanying “Letter of Information” and have had the nature of the study and
procedures to be used explained to me. All of my questions have been answered to my satisfaction.
By signing below, I agree to participate in this study

NAME (please print):

SIGNATURE:
DATE:

______________________________________

______________________________________

______________________________________

NAME OF PERSON OBTAINING INFORMED CONSENT (please print):

______________________________________
SIGNATURE OF PERSON OBTAINING INFORMED CONSENT:

______________________________________
DATE:

______________________________________
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Appendix V: Correlations

Estradiol

Progesterone

AG

GLP-1

FP

OP

LP

FP

OP

LP

FP

OP

LP

FP

OP

LP

Estradiol

-

-

-

-

-

-

0.13

-0.41

-0.76*

0.69

0.75*

0.82*

Progesterone

-

-

-

-

-

-

-0.26

0.18

-0.46

0.19

0.42

0.54

AG

0.13

-0.41

-0.76*

-0.26

0.18

-0.46

-

-

-

-

-

-

GLP-1

0.69

0.75*

0.82*

0.19

0.42

0.54

-

-

-

-

-

-
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Appendix VI: Individual Sex Hormone Concentrations

Progesterone (ng/ml)

80

Individual Progesterone
Concentrations

70
60
50
40
30
20
10
0

Estradiol (pg/ml)

300

Individual Estradiol
Concentrations

250
200
150
100
50
0
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Appendix VII: Absolute Concentrations of AG and GLP-1

AG:

Fasting

30 min

60 min

90 min

post-prandial

post-prandial

post-prandial

Follicular

524.0±394.4

354.8±205.4

333.1±157.1

397.6±161.2

Ovulatory

576.1±422.9

378.5±163.1

343.7±165.8

416.4±221.7

Luteal

607.6±268.7

474.0±266.4

388.9±220.5

534.1±283.9

30 min

60 min

90 min

post-prandial

post-prandial

post-prandial

GLP-1:

Fasting

Follicular

8.0±1.9

9.1±2.6

8.9±2.3

8.4±1.9

Ovulatory

7.6±1.2

9.2±2.9

9.7±2.6

8.2±1.7

Luteal

7.9±1.9

9.9±3.1

9.6±3.9

8.7±2.7
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